BJDX · Bluejay Diagnostics, Inc.
$1.07
-0.08 (-6.96%)
At close · Aug 7
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These financial results and financial position, and the Company's expected forward-looking outlook of significant negative cash flow in the future, raise substantial doubt with respect to its ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$1.19M
Shares
1.03M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Neil Dey | CEO | $473,555 |
| Jason Cook | CTO | $326,244 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Neil Dey | CEO | $290,887 |
| Jason Cook | CTO | $251,068 |
| Frances Scally | CFO | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kenneth Fisher | CFO | $395,311 |
| Neil Dey | CEO | $292,154 |
| Jason Cook | CTO | $240,304 |
| Frances Scally | CFO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Neil Dey | CEO | $425,438 |
| Kenneth Fisher | CFO | $374,173 |
| Jason Cook | CTO | $283,051 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jason Cook | CTO | $253,719 |
| Neil Dey | CEO | $181,610 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Neil Dey | CEO | $20,833 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jason Cook | Chief Technology Officer | Terminated | 2025-05-28 |